G1 THERAPEUTICS INC (GTHX) Forecast, Price Target & Analyst Ratings

NASDAQ:GTHX • US3621LQ1099

Current stock price

7.15 USD
0 (0%)
At close:
7.14 USD
-0.01 (-0.14%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for G1 THERAPEUTICS INC (GTHX).

Forecast Snapshot

Consensus Price Target

Price Target
$7.29
+ 2.00% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Oct 30, 2024
Period
Q3 / 2024
EPS Estimate
-$0.10
Revenue Estimate
18.404M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
74.55%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$7.29
Upside
+ 2.00%
From current price of $7.15 to mean target of $7.29, Based on 11 analyst forecasts
Low
$7.22
Median
$7.29
High
$7.51

Price Target Revisions

1 Month
58.89%
3 Months
-15.88%

Price Target Summary

11 Wall Street analysts provided a forecast for the next 12 months for GTHX. The average price target is 7.29 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 7.15.
The average price target has been revised downward by 15.88% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

GTHX Current Analyst RatingGTHX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

GTHX Historical Analyst RatingsGTHX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
74.55%
GTHX was analyzed by 11 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about GTHX.
In the last month the buy percentage fell by 5 points. So the trust of analysts is decreasing.
GTHX was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-08-07NeedhamDowngrade Buy -> Hold
2024-06-25NeedhamMaintains Buy -> Buy
2024-06-25HC Wainwright & Co.Maintains Buy -> Buy
2024-06-13NeedhamReiterate Buy -> Buy
2024-05-28NeedhamReiterate Buy -> Buy
2024-05-28HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-22NeedhamReiterate Buy -> Buy
2024-05-22HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-02HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-01NeedhamReiterate Buy -> Buy
2024-04-12NeedhamReiterate Buy -> Buy
2024-02-28NeedhamReiterate Buy -> Buy
2024-02-13NeedhamMaintains Buy -> Buy
2024-02-13WedbushMaintains Outperform -> Outperform
2024-01-24NeedhamReiterate Buy -> Buy
2023-12-06NeedhamReiterate Buy -> Buy
2023-10-30WedbushReiterate Outperform -> Outperform
2023-10-06JP MorganDowngrade Neutral -> Underweight
2023-08-03WedbushReiterate Outperform -> Outperform
2023-08-03HC Wainwright & Co.Reiterate Buy -> Buy
2023-08-02EF HuttonReiterate Buy
2023-08-02NeedhamMaintains Buy -> Buy
2023-06-26HC Wainwright & Co.Reiterate Buy -> Buy
2023-06-05NeedhamReiterate Buy -> Buy
2023-06-05HC Wainwright & Co.Reiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Oct 30, 2024
Period
Q3 / 2024
EPS Estimate
-$0.10
Revenue Estimate
18.404M
Revenue Q2Q
49.63%
EPS Q2Q
70.13%
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.20%
EPS (1 Month)
0.00%
EPS (3 Months)
24.07%

Next Earnings Summary

GTHX is expected to report earnings on 10/30/2024. The consensus EPS estimate for the next earnings is -0.1 USD and the consensus revenue estimate is 18.40M USD.
The next earnings revenue estimate has been revised upward by 0.2% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2024 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
GTHX revenue by date.GTHX revenue by date.
31.48M
-30.49%		51.3M
62.96%		82.511M
60.84%		75.014M
-9.09%		96.383M
28.49%		110.55M
14.70%		135.7M
22.75%		169.54M
24.94%		217.21M
28.12%		276.74M
27.41%
EBITDA
YoY % growth
GTHX ebitda by date.GTHX ebitda by date.
-141.99M
-48.06%		-135.65M
4.47%		-39.014M
71.24%		-25.607M
34.36%		-13.449M
47.48%		493.41M
3,768.83%		30.784M
-93.76%		48.124M
56.33%		60.925M
26.60%		66.484M
9.12%
EBIT
YoY % growth
GTHX ebit by date.GTHX ebit by date.
-142.46M
-47.66%		-136.18M
4.41%		-39.527M
70.97%		-25.141M
36.39%		-11.615M
53.80%		190.15M
1,737.11%		4.944M
-97.40%		28.275M
471.91%		72.453M
156.24%		116.92M
61.37%
Operating Margin
GTHX operating margin by date.GTHX operating margin by date.
-452.54%-265.46%-47.91%-33.52%-12.05%172.00%3.64%16.68%33.36%42.25%
EPS
YoY % growth
GTHX eps by date.GTHX eps by date.
-3.53
-34.22%		-3.39
3.97%		-0.95
71.98%		-0.42
55.71%		0.05
112.73%		0.22
319.05%		0.220.50
122.73%		0.85
70.41%		1.34
56.89%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.10
70.13%		-0.13
38.99%		-0.16
18.91%		-0.13
-25.46%		-0.09
13.66%		-0.05
57.40%		-0.11
32.70%		-0.10
19.51%		-0.08
9.60%		-0.07
-19.63%
Revenue
Q2Q % growth		18.404M
49.63%		21.041M
41.47%		19.136M
32.19%		21.706M
31.19%		24.305M
32.06%		26.657M
26.69%		18.006M
-5.91%		19.163M
-11.72%		20.341M
-16.31%		22.134M
-16.97%
EBITDA
Q2Q % growth		-3.871M
75.78%		-7.65M
9.10%		-2.04M
77.15%		-2.04M
38.07%		-2.04M
47.30%		-2.04M
73.33%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-4.39M
73.18%		-7.195M
19.41%		-7.987M
11.73%		-4.38M
-23.90%		-1.793M
59.15%		1.814M
125.21%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

GTHX Yearly Revenue VS EstimatesGTHX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
GTHX Yearly EPS VS EstimatesGTHX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 -2 -3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
30.77%
EPS Next 5 Year
20.36%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
10.30%
Revenue Next 5 Year
15.53%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
133.69%
EBIT Next 5 Year
24.98%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

G1 THERAPEUTICS INC / GTHX Forecast FAQ

What do analysts expect the price target to be for G1 THERAPEUTICS INC (GTHX)?

11 analysts have analysed GTHX and the average price target is 7.29 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 7.15.

When does G1 THERAPEUTICS INC (GTHX) report earnings?

G1 THERAPEUTICS INC (GTHX) will report earnings on 2024-10-30, after the market close.

Can you provide the consensus estimates for G1 THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of G1 THERAPEUTICS INC (GTHX) is -0.1 USD and the consensus revenue estimate is 18.40M USD.

How do analysts rate G1 THERAPEUTICS INC (GTHX)?

The consensus rating for G1 THERAPEUTICS INC (GTHX) is 74.5455 / 100 . This indicates that analysts generally have a positive outlook on the stock.